The American Journal of Managed Care

Proteomic Biomarkers Hold Promise in IPF

Proteomic mass spectrometry can identify key biomarkers in IPF, aiding in diagnosis and prognosis despite the disease's ...
Investing.com Australia

GRI Bio stock rises on positive Phase 2a immune data for IPF treatment

The Phase 2a trial enrolled 35 IPF patients randomized in a 2:1 ratio to receive either GRI-0621 or placebo once daily for 12 weeks. A sub-study examined immune cells in bronchoalveolar lavage fluid ...
The Manila Times

GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...
Frontiers

Diagnostic challenges and management strategies of pulmonary mucosa-associated lymphoid tissue lymphoma: a case report and literature review

1 Department of Respiratory and Critical Care Medicine, The People's Hospital of Neijiang Dongxing District, Neijiang, China 2 Department of Respiratory and Critical Care Medicine, The First ...